Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction
about
Update on heart failure with preserved ejection fraction.Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation.Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis.Assessment of Interleukin 16 Serum Levels and Skin Expression in Psoriasis Patients in Correlation with Clinical Severity of the Disease.Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patients.Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine.Complex relationship of obesity and obesity paradox in heart failure - higher risk of developing heart failure and better outcomes in established heart failure.Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity.Left atrial changes in early stages of heart failure with preserved ejection fraction.Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.
P2860
Q33640339-66A05BEE-268F-4299-8E94-02FB2B29898AQ34432633-E83A3B93-7BEB-420D-BD0D-3A51643F516BQ35026270-05F65C91-9057-47AD-BE51-1F5CAD4EC064Q36145584-FA047F8F-E011-4D52-8228-3F0235D8E541Q36176403-91F9EF25-1B63-4249-A2E3-02D8BE6A448CQ36570776-529BD0F6-CCD8-4816-B328-FFE9AA0DFD6FQ38764956-0D29CD62-75B5-4626-ACF3-4AE514A897B1Q38840828-508DA159-5AC9-497A-8F35-32D34BCB4A21Q41485370-A4B7FD00-A024-4B55-9D2D-5F8E3D0050A1Q51751022-F460EF2C-435E-4A78-A26B-73994C9DEFFCQ55271038-91D9171C-4692-4229-A817-83BA0CFA781D
P2860
Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Interleukin-16 promotes cardia ...... th preserved ejection fraction
@ast
Interleukin-16 promotes cardia ...... th preserved ejection fraction
@en
Interleukin-16 promotes cardia ...... th preserved ejection fraction
@nl
type
label
Interleukin-16 promotes cardia ...... th preserved ejection fraction
@ast
Interleukin-16 promotes cardia ...... th preserved ejection fraction
@en
Interleukin-16 promotes cardia ...... th preserved ejection fraction
@nl
prefLabel
Interleukin-16 promotes cardia ...... th preserved ejection fraction
@ast
Interleukin-16 promotes cardia ...... th preserved ejection fraction
@en
Interleukin-16 promotes cardia ...... th preserved ejection fraction
@nl
P2093
P2860
P1433
P1476
Interleukin-16 promotes cardia ...... th preserved ejection fraction
@en
P2093
Atsushi Kumanogoh
Daisuke Kamimura
Hidetoshi Hasuwa
Kazuhiro Yamamoto
Keisuke Hagihara
Makoto Kaneko
Mari Kawai
Mitsuru Higashimori
Ryohei Ishii
Shunsuke Tamaki
P2860
P304
P356
10.1371/JOURNAL.PONE.0068893
P407
P50
P577
2013-07-19T00:00:00Z